Sectoral Asset Management Inc Gilead Sciences, Inc. Transaction History

Sectoral Asset Management Inc

$203 Million
Q1 2024

A detailed history of Sectoral Asset Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 38,705 shares of GILD stock, worth $2.66 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

38,705

Previous 40,905 5.38%

Holding current value

$2.66 Million

Previous $3.31 Million 14.43%

% of portfolio

1.39%

Previous 1.51%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $157,476 - $192,038	-2,200 Reduced 5.38%	38,705 $2.84 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $201,858 - $228,912	2,755 Added 7.22%	40,905 $3.31 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $404,303 - $441,103	5,468 Added 16.73%	38,150 $2.86 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $530,701 - $605,339	6,982 Added 27.17%	32,682 $2.52 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $27,058 - $30,828	-350 Reduced 1.34%	25,700 $2.13 Million

Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $645,012 - $926,014	-10,350 Reduced 28.43%	26,050 $2.24 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $658,008 - $741,114	11,400 Added 45.6%	36,400 $2.25 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $121,632 - $152,418	2,100 Added 9.17%	25,000 $1.49 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $411,988 - $467,614	-6,350 Reduced 21.71%	22,900 $1.66 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $18,000 - $20,537	-300 Reduced 1.02%	29,250 $1.89 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $2 Million - $2.28 Million	-35,350 Reduced 54.47%	29,550 $1.72 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $1.69 Million - $2.13 Million	-27,250 Reduced 29.57%	64,900 $4.1 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $2.06 Million - $2.39 Million	28,500 Added 44.78%	92,150 $7.09 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $770,349 - $986,706	12,300 Added 23.95%	63,650 $4.76 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $12.1 Million - $13.3 Million	-195,590 Reduced 79.21%	51,350 $3.34 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $9.45 Million - $10.4 Million	-151,100 Reduced 37.96%	246,940 $15.7 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $2.36 Million - $2.64 Million	-38,100 Reduced 8.74%	398,040 $26.9 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $703,462 - $788,062	11,250 Added 2.65%	436,140 $28.4 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $9.61 Million - $12.5 Million	158,750 Added 59.65%	424,890 $26.6 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $138,283 - $153,104	1,940 Added 0.73%	266,140 $20.5 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $3.84 Million - $4.48 Million	59,200 Added 28.88%	264,200 $18.7 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $14.9 Million - $18.2 Million	205,000 New	205,000 $15.5 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $16.7 Million - $19.6 Million	-234,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $16.9 Million - $20.1 Million	234,900	234,900 $19 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account

Sectoral Asset Management Inc Gilead Sciences, Inc. Transaction History